• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过基因敲除糖尿病OVE小鼠中的非典型趋化因子受体ACKR2实现肾脏保护

Renal Protection by Genetic Deletion of the Atypical Chemokine Receptor ACKR2 in Diabetic OVE Mice.

作者信息

Zheng Shirong, Coventry Susan, Cai Lu, Powell David W, Jala Venkatakrishna R, Haribabu Bodduluri, Epstein Paul N

机构信息

Department of Pediatrics, University of Louisville, Louisville, KY 40202, USA.

Department of Pathology, University of Louisville, Louisville, KY 40202, USA.

出版信息

J Diabetes Res. 2016;2016:5362506. doi: 10.1155/2016/5362506. Epub 2015 Dec 20.

DOI:10.1155/2016/5362506
PMID:26798651
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4699014/
Abstract

In diabetic nephropathy (DN) proinflammatory chemokines and leukocyte infiltration correlate with tubulointerstitial injury and declining renal function. The atypical chemokine receptor ACKR2 is a chemokine scavenger receptor which binds and sequesters many inflammatory CC chemokines but does not transduce typical G-protein mediated signaling events. ACKR2 is known to regulate diverse inflammatory diseases but its role in DN has not been tested. In this study, we utilized ACKR2(-/-) mice to test whether ACKR2 elimination alters progression of diabetic kidney disease. Elimination of ACKR2 greatly reduced DN in OVE26 mice, an established DN model. Albuminuria was significantly lower at 2, 4, and 6 months of age. ACKR2 deletion did not affect diabetic blood glucose levels but significantly decreased parameters of renal inflammation including leukocyte infiltration and fibrosis. Activation of pathways that increase inflammatory gene expression was attenuated. Human biopsies stained with ACKR2 antibody revealed increased staining in diabetic kidney, especially in some tubule and interstitial cells. The results demonstrate a significant interaction between diabetes and ACKR2 protein in the kidney. Unexpectedly, ACKR2 deletion reduced renal inflammation in diabetes and the ultimate response was a high degree of protection from diabetic nephropathy.

摘要

在糖尿病肾病(DN)中,促炎趋化因子和白细胞浸润与肾小管间质损伤及肾功能下降相关。非典型趋化因子受体ACKR2是一种趋化因子清除受体,它能结合并隔离多种炎性CC趋化因子,但不转导典型的G蛋白介导的信号事件。已知ACKR2可调节多种炎性疾病,但其在糖尿病肾病中的作用尚未得到验证。在本研究中,我们利用ACKR2基因敲除小鼠来测试去除ACKR2是否会改变糖尿病肾病的进展。去除ACKR2可显著减轻OVE26小鼠(一种已建立的糖尿病肾病模型)的糖尿病肾病。在2、4和6月龄时,蛋白尿水平显著降低。ACKR2基因缺失不影响糖尿病小鼠的血糖水平,但可显著降低包括白细胞浸润和纤维化在内的肾脏炎症参数。增加炎性基因表达的信号通路激活减弱。用ACKR2抗体染色的人肾活检组织显示,糖尿病肾病患者肾脏中的染色增加,尤其是在一些肾小管和间质细胞中。结果表明,糖尿病与肾脏中的ACKR2蛋白之间存在显著相互作用。出乎意料的是,ACKR2基因缺失可减轻糖尿病患者的肾脏炎症,最终的反应是对糖尿病肾病具有高度保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab46/4699014/29d8a9ee7e02/JDR2016-5362506.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab46/4699014/b909bcaaa706/JDR2016-5362506.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab46/4699014/e9e7f5b28674/JDR2016-5362506.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab46/4699014/daae88190414/JDR2016-5362506.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab46/4699014/1de690a7d135/JDR2016-5362506.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab46/4699014/0b85803be72c/JDR2016-5362506.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab46/4699014/29d8a9ee7e02/JDR2016-5362506.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab46/4699014/b909bcaaa706/JDR2016-5362506.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab46/4699014/e9e7f5b28674/JDR2016-5362506.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab46/4699014/daae88190414/JDR2016-5362506.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab46/4699014/1de690a7d135/JDR2016-5362506.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab46/4699014/0b85803be72c/JDR2016-5362506.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab46/4699014/29d8a9ee7e02/JDR2016-5362506.006.jpg

相似文献

1
Renal Protection by Genetic Deletion of the Atypical Chemokine Receptor ACKR2 in Diabetic OVE Mice.通过基因敲除糖尿病OVE小鼠中的非典型趋化因子受体ACKR2实现肾脏保护
J Diabetes Res. 2016;2016:5362506. doi: 10.1155/2016/5362506. Epub 2015 Dec 20.
2
The atypical chemokine receptor 2 limits renal inflammation and fibrosis in murine progressive immune complex glomerulonephritis.非典型趋化因子受体 2 限制了小鼠进行性免疫复合物性肾小球肾炎中的肾脏炎症和纤维化。
Kidney Int. 2018 Apr;93(4):826-841. doi: 10.1016/j.kint.2017.11.013. Epub 2018 Feb 1.
3
Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.实验性糖尿病肾病中蛋白尿、炎症和纤维化发展过程中TLR2的需求
Int J Clin Exp Pathol. 2014 Jan 15;7(2):481-95. eCollection 2014.
4
The Atypical Chemokine Receptor 2 Limits Progressive Fibrosis after Acute Ischemic Kidney Injury.非典型趋化因子受体 2 限制急性缺血性肾损伤后的进行性纤维化。
Am J Pathol. 2019 Feb;189(2):231-247. doi: 10.1016/j.ajpath.2018.09.016. Epub 2018 Nov 16.
5
The atypical chemokine receptor 2 reduces T cell expansion and tertiary lymphoid tissue but does not limit autoimmune organ injury in lupus-prone B6lpr mice.非典型趋化因子受体 2 可减少 T 细胞扩增和三级淋巴组织形成,但不能限制狼疮易感 B6.lpr 小鼠的自身免疫性器官损伤。
Front Immunol. 2024 May 10;15:1377913. doi: 10.3389/fimmu.2024.1377913. eCollection 2024.
6
Atypical chemokine receptor ACKR2 mediates chemokine scavenging by primary human trophoblasts and can regulate fetal growth, placental structure, and neonatal mortality in mice.非典型趋化因子受体ACKR2介导原代人滋养层细胞的趋化因子清除,并可调节小鼠的胎儿生长、胎盘结构和新生儿死亡率。
J Immunol. 2014 Nov 15;193(10):5218-28. doi: 10.4049/jimmunol.1401096. Epub 2014 Oct 8.
7
Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.足细胞特异性趋化因子(C-C基序)受体2的过表达介导小鼠糖尿病肾损伤。
Kidney Int. 2017 Mar;91(3):671-682. doi: 10.1016/j.kint.2016.09.042. Epub 2016 Dec 1.
8
Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice.降低尿酸对2型糖尿病db/db小鼠肾脏疾病的影响。
Am J Physiol Renal Physiol. 2009 Aug;297(2):F481-8. doi: 10.1152/ajprenal.00092.2009. Epub 2009 May 20.
9
Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury.巨噬细胞衍生的肿瘤坏死因子-α介导糖尿病肾损伤。
Kidney Int. 2015 Oct;88(4):722-33. doi: 10.1038/ki.2015.162. Epub 2015 Jun 10.
10
The scavenging chemokine receptor ACKR2 has a significant impact on acute mortality rate and early lesion development after traumatic brain injury.趋化因子清除受体ACKR2对创伤性脑损伤后的急性死亡率和早期损伤发展有重大影响。
PLoS One. 2017 Nov 27;12(11):e0188305. doi: 10.1371/journal.pone.0188305. eCollection 2017.

引用本文的文献

1
Phosphoproteomic mapping of CCR5 and ACKR2 signaling properties.CCR5和ACKR2信号特性的磷酸化蛋白质组学图谱分析
Front Mol Biosci. 2022 Nov 22;9:1060555. doi: 10.3389/fmolb.2022.1060555. eCollection 2022.
2
CD45 Immunohistochemistry in Mouse Kidney.小鼠肾脏中的CD45免疫组织化学
Bio Protoc. 2021 Nov 20;11(22):e4230. doi: 10.21769/BioProtoc.4230.
3
The kidney, COVID-19, and the chemokine network: an intriguing trio.肾脏、COVID-19 和趋化因子网络:一个有趣的三联体。

本文引用的文献

1
Inflammation in diabetic kidney disease.糖尿病肾病中的炎症。
World J Diabetes. 2014 Aug 15;5(4):431-43. doi: 10.4239/wjd.v5.i4.431.
2
Expression of the chemokine decoy receptor D6 mediates dendritic cell function and promotes corneal allograft rejection.趋化因子诱饵受体D6的表达介导树突状细胞功能并促进角膜移植排斥反应。
Mol Vis. 2013 Dec 16;19:2517-25. eCollection 2013.
3
Diabetic kidney disease and immune modulation.糖尿病肾病与免疫调节。
Int Urol Nephrol. 2021 Jan;53(1):97-104. doi: 10.1007/s11255-020-02579-8. Epub 2020 Jul 27.
4
The Role of Chemokines and Chemokine Receptors in Diabetic Nephropathy.趋化因子及其受体在糖尿病肾病中的作用。
Int J Mol Sci. 2020 Apr 30;21(9):3172. doi: 10.3390/ijms21093172.
5
Roles of pattern recognition receptors in diabetic nephropathy.模式识别受体在糖尿病肾病中的作用。
J Zhejiang Univ Sci B. 2020;21(3):192-203. doi: 10.1631/jzus.B1900490.
6
Clopidogrel Reduces Fibronectin Accumulation and Improves Diabetes-Induced Renal Fibrosis.氯吡格雷减少纤维连接蛋白的积累并改善糖尿病引起的肾脏纤维化。
Int J Biol Sci. 2019 Jan 1;15(1):239-252. doi: 10.7150/ijbs.29063. eCollection 2019.
7
The scavenging chemokine receptor ACKR2 has a significant impact on acute mortality rate and early lesion development after traumatic brain injury.趋化因子清除受体ACKR2对创伤性脑损伤后的急性死亡率和早期损伤发展有重大影响。
PLoS One. 2017 Nov 27;12(11):e0188305. doi: 10.1371/journal.pone.0188305. eCollection 2017.
8
Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease.血清素及其受体作为糖尿病肾病的新型抗氧化治疗靶点。
J Diabetes Res. 2017;2017:7680576. doi: 10.1155/2017/7680576. Epub 2017 Aug 8.
9
Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation.细胞因子诱饵受体和清道夫受体作为免疫和炎症的关键调节因子。
Cytokine. 2016 Nov;87:37-45. doi: 10.1016/j.cyto.2016.06.023. Epub 2016 Aug 4.
10
Atypical Chemokine Receptors and Their Roles in the Resolution of the Inflammatory Response.非典型趋化因子受体及其在炎症反应消退中的作用。
Front Immunol. 2016 Jun 10;7:224. doi: 10.3389/fimmu.2016.00224. eCollection 2016.
Curr Opin Pharmacol. 2013 Aug;13(4):602-12. doi: 10.1016/j.coph.2013.05.002. Epub 2013 May 27.
4
Inflammation in diabetic nephropathy.糖尿病肾病中的炎症。
Mediators Inflamm. 2012;2012:146154. doi: 10.1155/2012/146154. Epub 2012 Aug 21.
5
Elevated expression of the chemokine-scavenging receptor D6 is associated with impaired lesion development in psoriasis.趋化因子清除受体 D6 的高表达与银屑病皮损发展受损有关。
Am J Pathol. 2012 Oct;181(4):1158-64. doi: 10.1016/j.ajpath.2012.06.042. Epub 2012 Aug 4.
6
Expression of the atypical chemokine receptor D6 in human alveolar macrophages in COPD.在 COPD 患者的人肺泡巨噬细胞中表达非典型趋化因子受体 D6。
Chest. 2013 Jan;143(1):98-106. doi: 10.1378/chest.11-3220.
7
Control of murine Ly6C(high) monocyte traffic and immunosuppressive activities by atypical chemokine receptor D6.非典型趋化因子受体 D6 对小鼠 Ly6C(high) 单核细胞迁移和免疫抑制活性的控制作用。
Blood. 2012 May 31;119(22):5250-60. doi: 10.1182/blood-2011-10-388082. Epub 2012 Apr 13.
8
The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions.足细胞中 MCP-1/CCR2 轴参与糖尿病条件诱导的细胞凋亡。
Apoptosis. 2012 Jan;17(1):1-13. doi: 10.1007/s10495-011-0661-6.
9
Uninephrectomy of diabetic OVE26 mice greatly accelerates albuminuria, fibrosis, inflammatory cell infiltration and changes in gene expression.单侧肾切除的糖尿病 OVE26 小鼠极大加速了蛋白尿、纤维化、炎症细胞浸润和基因表达改变。
Nephron Exp Nephrol. 2011;119(1):e21-32. doi: 10.1159/000327586. Epub 2011 Jun 9.
10
Inflammatory gene expression in OVE26 diabetic kidney during the development of nephropathy.在 OVE26 糖尿病肾病发生发展过程中肾脏的炎症基因表达。
Nephron Exp Nephrol. 2011;119(1):e8-20. doi: 10.1159/000324407. Epub 2011 May 23.